Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for an investigational vaccine therapy in stage IV hormone receptor-positive breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer, Male Breast Cancer | Phase 2 | Status: TERMINATED